PI vs REGN · rev $366.1M vs P/E 14, rev $14.34B
Impinj Inc (PI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Impinj Inc (PI) is a semiconductors company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PI revenue for 2024-12-31 was $366.1M. Net income was $40.8M. Revenue was up 19.0% from 2023-12-31 to 2024-12-31. PI currently screens at market cap $3.36B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PI currently screens at market cap $3.36B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PI and REGN stock pages for the full models.
Not investment advice.